- Home
- TMDX vs FULT Comparison
TMDX vs FULT Comparison
Compare TMDX & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- FULT
- Stock Information
- Founded
- TMDX 1998
- FULT 1882
- Country
- TMDX United States
- FULT United States
- Employees
- TMDX N/A
- FULT N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FULT Major Banks
- Sector
- TMDX Health Care
- FULT Finance
- Exchange
- TMDX Nasdaq
- FULT Nasdaq
- Market Cap
- TMDX 3.9B
- FULT 3.3B
- IPO Year
- TMDX 2019
- FULT N/A
- Fundamental
- Price
- TMDX $114.30
- FULT $17.75
- Analyst Decision
- TMDX Buy
- FULT Hold
- Analyst Count
- TMDX 11
- FULT 4
- Target Price
- TMDX $130.73
- FULT $20.50
- AVG Volume (30 Days)
- TMDX 1.0M
- FULT 1.6M
- Earning Date
- TMDX 10-29-2025
- FULT 10-21-2025
- Dividend Yield
- TMDX N/A
- FULT 4.05%
- EPS Growth
- TMDX 170.70
- FULT 20.91
- EPS
- TMDX 2.54
- FULT 1.91
- Revenue
- TMDX $566,354,000.00
- FULT $1,230,470,000.00
- Revenue This Year
- TMDX $38.84
- FULT N/A
- Revenue Next Year
- TMDX $20.46
- FULT N/A
- P/E Ratio
- TMDX $45.35
- FULT $9.30
- Revenue Growth
- TMDX 41.20
- FULT 9.56
- 52 Week Low
- TMDX $55.00
- FULT $14.33
- 52 Week High
- TMDX $145.50
- FULT $22.49
- Technical
- Relative Strength Index (RSI)
- TMDX 40.85
- FULT 49.16
- Support Level
- TMDX $115.21
- FULT $17.19
- Resistance Level
- TMDX $125.57
- FULT $18.08
- Average True Range (ATR)
- TMDX 7.65
- FULT 0.38
- MACD
- TMDX -1.72
- FULT 0.06
- Stochastic Oscillator
- TMDX 12.41
- FULT 68.00
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About FULT Fulton Financial Corporation
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.